Connected profileLeuprolide
Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Leuprolide clinical trials
12 selected ClinicalTrials.gov records carrying the official matched intervention Leuprolide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
Registry records
12 selected records.
Connected peptides
1 profiles.
Source boundary
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 47 selected PubMed records and 24 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
Record added
ClinicalTrials.gov record NCT07596212
PeptideScanner retained ClinicalTrials.gov record NCT07596212 at 2026-09-09T19:17:17.112Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- August 24, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT07801664
PeptideScanner retained ClinicalTrials.gov record NCT07801664 at 2026-09-09T19:17:17.074Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- September 3, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT07455903
PeptideScanner retained ClinicalTrials.gov record NCT07455903 at 2026-08-13T05:52:27.015Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- August 6, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Leuprolide · 2026-09-03
ClinicalTrials.gov record NCT07801664
Recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-08-24
ClinicalTrials.gov record NCT07596212
Not yet recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-08-06
ClinicalTrials.gov record NCT07455903
Recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-07-30
ClinicalTrials.gov record NCT05765500
Recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-07-20
ClinicalTrials.gov record NCT06378866
Recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-07-10
ClinicalTrials.gov record NCT05498272
Active, not recruiting at the retained observation.
Open attributed record →Leuprolide · 2019-07-24
ClinicalTrials.gov record NCT00669162
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-12-13
ClinicalTrials.gov record NCT00928434
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-12-05
ClinicalTrials.gov record NCT01750398
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-04-28
ClinicalTrials.gov record NCT00500110
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-01-29
ClinicalTrials.gov record NCT00631527
Completed at the retained observation.
Open attributed record →Leuprolide · 2014-05-14
ClinicalTrials.gov record NCT01160328
Completed at the retained observation.
Open attributed record →